Skip to main content
. 2017 May 12;2017:bcr2017219919. doi: 10.1136/bcr-2017-219919

Figure 2.

Figure 2

Nivolumab was reinitiated due to progression (A). After 1 month, CT revealed the lung cancer and metastases, especially the left cervical lymph nodes, became larger (B).